Double-Blind Randomised Investigation of Tibolone Alone or in Adjunct to Standard Antidepressant Treatment for Depression in Menopausal Women

Trial Profile

Double-Blind Randomised Investigation of Tibolone Alone or in Adjunct to Standard Antidepressant Treatment for Depression in Menopausal Women

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 11 Aug 2017

At a glance

  • Drugs Tibolone (Primary)
  • Indications Depressive disorders; Menopausal syndrome
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Aug 2017 Planned End Date changed from 1 Jan 2017 to 1 Dec 2019.
    • 07 Aug 2017 Planned primary completion date changed from 1 Jan 2017 to 1 Dec 2019.
    • 22 Jan 2016 Planned number of patients changed from 30 to 120 as per ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top